Sterling Investment Counsel’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Sterling Investment Counsel's GILD Position: Q2 2026 in Review
Sterling Investment Counsel increased its Gilead Sciences (GILD) stake by 2.3% in Q2 2026, buying an estimated $27K and bringing the position to 9,013 shares worth $1.14M. The position accounts for 0.27% of the portfolio, ranked #63.
Sterling Investment Counsel first reported a position in GILD in Q4 2022 and has held it in 13 quarters since. The position peaked at $1.23M in Q1 2026. 1,032 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Sterling Investment Counsel held 9,013 shares of Gilead Sciences worth $1.14M as of Q2 2026.
- Sterling Investment Counsel bought 205 Gilead Sciences shares in Q2 2026, an estimated $27K.
- Gilead Sciences made up 0.27% of Sterling Investment Counsel's portfolio in Q2 2026, its #63 holding.
- Sterling Investment Counsel first reported a position in Gilead Sciences in Q4 2022 and has held it in 13 quarters since.
- Sterling Investment Counsel's Gilead Sciences position peaked at $1.23M in Q1 2026.
- 1,032 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Sterling Investment Counsel's 13F filing for Q2 2026, filed 20 Jul 2026.